Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day. Welcome to the Aytu BioPharma Fiscal twenty twenty six Q3 Earnings Call. At this time, participants are in a listen only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Robert Plume, Investor Relations. You may begin. Great. Thank you very much and good afternoon everyone. As the operator indicated, during today's call, we will be discussing Aytu BioPharma's fiscal twenty twenty six third quarter operational and financial results for the period ended 03/31/2026. Joining us on today's call is Aytu's Chief Executive Officer, Josh Disbrow and Ryan Selhorn, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we'll open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today or by utilizing the link on the company's website under Events and Presentations. Finally, I'd also like to call to your attention the customary Safe Harbor disclosure regarding forward looking information. The conference call today will contain certain forward looking statements, including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Aytu BioPharma. Although management believes these statements are reasonable based on estimates, assumptions and projections as of today, these statements are not guarantees of future performance. Time sensitive information may no longer be accurate at the time of any telephonic or webcast replay. Actual results may differ materially as a result of risks...